arsenic has been researched along with Lymphoma, Primary Effusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou Merhi, R; Ali, J; Bazarbachi, A; Daher, A; El Hajj, H; El Sabban, M; Ghantous, A; Hodroj, D; Journo, C; Mahieux, R; Otrock, Z; Zaatari, G; Zibara, K | 1 |
1 other study(ies) available for arsenic and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomas.
Topics: Animals; Apoptosis; Arsenic; Cell Line, Tumor; Drug Synergism; Herpesvirus 8, Human; Humans; Interferon-alpha; Lymphoma, Primary Effusion; Mice; Transcription, Genetic | 2013 |